We suggest that classic psychedelic-assisted therapies can be integrated into most mainstream evidence-based SUD treatments that are currently used in clinical settings, indicating broad compatibility of classic psychedelics with contemporary SUD treatment paradigms.

Evidence is now building for psychedelics' safety and efficacy in treating a range of psychiatric disorders including addiction.